Johnson & Johnson - 52 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. The latest closing stock price for Johnson & Johnson as of December 02, 2022 is 178.88.
  • The all-time high Johnson & Johnson stock closing price was 182.44 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 186.69, which is 4.4% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 155.72, which is 12.9% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 171.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 169.6966 167.1598 182.4364 155.1019 178.8800 7.31%
2021 159.1892 148.7411 172.7034 146.3889 166.7018 11.45%
2020 136.6646 135.0276 149.5775 103.4780 149.5775 10.85%
2019 123.6067 115.7980 135.4624 113.9579 134.9351 15.35%
2018 118.9263 122.8769 134.0084 106.8319 116.9764 -5.14%
2017 113.0796 99.6616 126.1070 96.1514 123.3093 24.40%
2016 96.4257 84.0757 106.4334 80.1179 99.1196 15.32%
2015 82.2154 84.9254 88.0669 75.3659 85.9500 1.16%
2014 80.8318 71.9703 88.1755 68.4837 84.9661 17.34%
2013 66.8359 54.3605 75.6072 54.2838 72.4131 34.62%
2012 50.4378 48.7600 55.1659 46.5757 53.7927 10.83%
2011 46.1707 44.8617 49.3687 41.5496 48.5379 9.89%
2010 43.5746 44.6138 45.8948 39.9948 44.1689 -0.58%
2009 39.2281 40.4727 44.8070 31.3587 44.4276 11.28%
2008 42.6791 42.7758 47.8166 36.9226 39.9255 -7.77%
2007 40.9806 42.0207 44.3918 38.1925 43.2885 3.61%
2006 38.9059 38.1022 43.4818 35.1161 41.7803 12.44%
2005 39.5856 38.1320 42.2526 37.1192 37.1563 -3.36%
2004 33.5700 30.7169 38.6534 29.5619 38.4473 25.17%
2003 30.9943 32.3269 34.4153 28.8419 30.7169 -2.11%
2002 33.4395 33.8337 37.8659 24.2781 31.3804 -7.88%
2001 29.7495 29.0074 35.1421 23.7556 34.0642 13.97%
2000 25.2669 25.9105 29.8890 19.3219 29.8890 14.04%
1999 26.2879 22.9741 29.8199 21.3932 26.2084 12.46%
1998 20.7196 17.8428 24.7272 17.5520 23.3047 28.99%
1997 16.2501 13.4523 18.3583 13.4523 18.0676 34.31%
1996 13.0262 11.2232 14.5339 11.2232 13.4523 18.11%
1995 9.0951 7.1242 12.1889 7.0261 11.3897 59.14%
1994 5.9758 5.7729 7.2719 4.7178 7.1569 25.00%
1993 5.2926 6.1628 6.1628 4.5182 5.7257 -8.93%
1992 6.0895 6.8629 7.1154 5.3197 6.2873 -10.19%
1991 5.4375 4.2070 7.0616 3.9438 7.0005 62.34%
1990 3.7403 3.5243 4.3659 3.0605 4.3122 23.39%
1989 2.9158 2.4071 3.4949 2.4071 3.4949 42.64%
1988 2.3022 2.1939 2.5210 1.9760 2.4502 16.52%
1987 2.4032 1.8648 2.9224 1.8017 2.1029 15.79%
1986 1.7460 1.4052 2.0342 1.2933 1.8161 27.43%
1985 1.1906 0.9380 1.4829 0.9248 1.4252 49.85%
1984 0.8865 1.0398 1.0780 0.7307 0.9511 -8.53%
1983 1.1474 1.2299 1.2711 0.9984 1.0398 -15.66%
1982 1.0036 0.8882 1.2672 0.7929 1.2329 36.93%
1981 0.8179 0.7871 0.9213 0.6868 0.9004 14.54%
1980 0.6172 0.5882 0.7880 0.5132 0.7861 29.42%
1979 0.5450 0.5535 0.6132 0.4927 0.6074 10.48%
1978 0.5662 0.5469 0.6579 0.4833 0.5498 -1.77%
1977 0.5080 0.5581 0.5597 0.4498 0.5597 0.43%
1976 0.6131 0.6361 0.6794 0.5144 0.5573 -12.03%
1975 0.6251 0.5804 0.6956 0.5157 0.6335 12.00%
1974 0.6861 0.7754 0.8273 0.5240 0.5656 -27.70%
1973 0.8229 0.8876 0.9014 0.7251 0.7823 -13.21%
1972 0.8133 0.6727 0.9119 0.6528 0.9014 32.99%
1971 0.5845 0.3919 0.6804 0.3919 0.6778 73.71%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $467.313B $93.775B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $351.879B 44.40
Pfizer (PFE) United States $286.728B 7.83
AbbVie (ABBV) United States $285.840B 11.85
Novo Nordisk (NVO) Denmark $285.428B 37.43
Merck (MRK) United States $278.387B 14.33
Novartis AG (NVS) Switzerland $198.736B 14.97